Muscular dystrophy in adult and aged anti-NGF transgenic mice resembles an inclusion body myopathy

Journal of Neuroscience Research

Volumn 59, Issue 4, 2000, Pages 553-560

  Capsoni, Simona ^a   Ruberti, Francesca ^a,b   Di Daniel, Elena ^a   Cattaneo, Antonino ^a  

^a SISSA   (Italy)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

Adult transgenic mice; Ageing; Atrophy; Inflammation; Myopathy; NGF

Indexed keywords

NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY;

AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; IMMUNOHISTOCHEMISTRY; INCLUSION BODY MYOSITIS; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; MICE; MICE, TRANSGENIC; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MYOSITIS, INCLUSION BODY; NERVE GROWTH FACTOR; PHENOTYPE; TRIGEMINAL GANGLION;

EID: 0034651690     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000215)59:4<553::AID-JNR11>3.0.CO;2-4     Document Type: Article

References (40)

1. Aloe L, Cozzan C, Calissano P, Levi-Montalcini R. 1981. Somatic and behavioural postnatal effects of fetal injections of nerve growth factor antibodies in the rat. Nature 291:413-415.
2. Askanas V, Engel WK, Alvarez RB. 1993. Enhanced detection of Congo-red positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique. Neurology 43:1265-1267.
3. Baskar JF, Smith PP, Nilaver G, Jupp RA, Hoffmann S, Peffer NJ, Tenney DJ, Colberg-Poley AM, Ghazal P, Nelson JA. 1996. The enhancer domain of the human cytomegalovirus major immediate-early promoter deermines cell type-specific expression in transgenic mice. J Virol 70:3207-3214.
4. Baron P, Scarpini E, Meola G, Santilli I, Conti G, Pleasure D, Scarlato G. 1994. Expression of the low affinity NGF receptor during human muscle development, regeneration, and in tissue culture. Muscle Nerve 17:276-284.
5. Boshart M, Weber F, Jahn G, Dorsch-Asler K, Fleckenstein B, Schaffner W. 1985. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521-530.
6. Brodie C, Sampson SR. 1990. Nerve growth factor and fibroblast growth factor influence post-fusion expression of Na-channels in cultured rat skeletal muscle. J Cell Physiol 144:492-497.
7. Cattaneo A, Rapposelli B, Calissano P. 1988. Three distinct types of monoclonal antibodies after long term immunization of rats with mouse NGF. J Neurochem 50:1003-1010.
8. Cattaneo A, Capsoni S, Margotti E, Righi M, Kontsekova E, Pavlik P, Filipcik P, Novak M. 1999. Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody. J Neurosci 19:9687-9697.
9. Chen KS, Nishimura MC, Armanini MP, Crowley C, Spencer SD, Philipps HS. 1997. Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits. J Neurosci 17:7228-7296.
10. Conover JC, Yancopoulos GD. 1997. Neurotrophin regulation of the developing nervous system: analyses of knockout mice. Rev Neurosci 8:13-27.
11. Crowley C, Spencer SD, Nishimura MC, Chen KS, Pitts-Meek S, Armanini MP, Lanway HL, McMahon SB, Shelton DL, Levinson AD, Phillips HS. 1994. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76:1001-1011.
12. Dalakas MC, Ilia I. 1995. Common variable immunodeficiency and inclusion body myositis: a distinct myopathy mediated by natural killer cells. Ann Neurol 37:806-810.
13. Davies AM, Wyatt S, Nishimura M, Phillips H. 1995. NGF receptor expression in sensory neurons develops normally in embryos lacking NGF. Dev Biol 171:434-438.
14. Erck C, Meisinger C, Grothe C, Seidl K. 1998. Regulation of nerve growth factor and its low-affinity receptor (p75NTR) during myogenic differentiation. J Cell Physiol 176:22-31.
15. Ernfors P, Wetmore C, Eriksdotter-Nilsson M, Bygdeman M, Stromberg I, Olson L, Persson H. 1991. The nerve growth factor receptor gene is expressed in both neuronal and non neuronal tissues in the human fetus. Int J Dev Neurosci 9:37-66.
16. Furukuwa S, Hayashi K. 1979. Level of nerve growth factor-like immunoreactivity in the lower limb muscles of muscular dystrophic mice. Biochem Biophys Res Commun 90:130-134.
17. Furukuwa S, Nishitani S, Hayashi K. 1977. Level of nerve growth factor activity in the submaxillary glands of genetically dystrophic mouse (C57BL/6J). Biochem Biophys Res Commun 76:1202-1206.
18. Gonfloni S. 1995. Recombinat antibodies as structural probes for neurotrophins. SISSA. PhD Thesis.
19. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, Rowland LP. 1995. Inclusion body myositis and myopathies. Ann Neurol 38:705-713.
20. Heumann R, Korsching S, Scott J, Thoenen H. 1984. Reletionship between levels of nerve growth factor (NGF) and its messenger RNA in sympathethic ganglia and peripheral target tissues. EMBO J 3:3183-3189.
21. Heuer JG, Fatemie-Nainie S, Wheeler EF, Bothwell M. 1990. Structure and developmental expression of the chicken NGF receptor. Dev Biol 137:287-304.
22. Jin L-W, Hearn MG, Ogbum CE, Dang N, Nochlin D, Ladiges WC, Martin GM. 1998. Transgenic mice over-expressing the C-99 fragment of βPP with an α-secretase site mutation develop a myopathy similar to human inclusion body myositis. Am J Pathol 153:1679-1686.
23. Lee K-F, Li E, Huber LJ, Landis SC, Sharpe AH, Chao MV, Jaenisch R. 1992. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 6:737-749.
24. Levi-Montalcini R. 1987. The nerve growth factor 35 years later. Science 237:1154-1162.
25. Mardy S, Miura Y, Endo F, Matsuda I, Sztriha L, Frossard P, Moosa A, Ismail EA, Macaya A, Andria G, Toscano E, Gibson W, Graham GE, Indo Y. 1999. Congenital insensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor. Am J Hum Genet 64:1570-1579.
26. Mikol J, Engel AG. 1994. Inclusion body myositis. In: Engel AG, Franzini-Armstrong C, editors. Myology: basic and clinical. New York: McGraw-Hill. p. 1384-1398.
27. Molnar M, Tongiorgi E, Avignone E, Gonfloni S, Ruberti F, Domenici L, Cattaneo A. 1998. The effects of anti-nerve growth factor monoclonal antibodies on developing basal forebrain neurons are transient and reversible. Eur J Neurosci 10:3127-3140.
28. Piccioli P, Di Luzio A, Amann R, Schuligoi R, Azim Surani M, Donnerer J, Cattaneo A. 1995. Neuroantibodies: ectopic expression of a recombinant anti-substance P antibody in the central nervous system of transgenic mice. Neuron 15:373-384.
29. Raivich G, Zimmermann A, Sutter A. 1985. The spatial and temporal pattern of beta NGF receptor expression in the developing chick embryo. EMBO J 4:637-644.
30. Ruberti F, Bradbury A, Cattaneo A. 1993. Cloning and expression of an anti-nerve growth factor (NGF) antibody for studies using the neuroantibody approach. Cell Mol Neurobiol 13:559-568.
31. Seidl K, Erck C, Buchberger A. 1998. Evidence for the partecipation of nerve growth factor and its low-affinity receptor (p75NTR) in the regulation of the myogenic program. J Cell Physiol 176:10-21.
32. Sendtner M, Holtmann B, Hughes RA. 1996. The response of motoneurons to neurotrophins. Nerochem Res 21:831-841.
33. Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, Lira SA, Barbacid M. 1994. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368:246-249.
34. Snider WD. 1994. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77:627-638.
35. Van den Pol AN, Ghosh PK. 1998. Selective neuronal expression of green fluorescent protein with cytomegalovirus promoter reveales entire neuronal arbor in transgenic mice. J Neurosci 18:10640-10651.
36. Vigdor-Alboim S, Rothman C, Braiman L, Bak A, Langzam L, Yosef O, Sterengarz BB, Nawrath H, Brodie C, Sampson SR. 1999. Discoordinate regulation of different K channels in cultured rat skeletal muscle by nerve growth factor. J Neurosci Res 56:275-283.
37. Vogel H. 1998. Inclusion body myositis - a review. Adv Anat Pathol 5:164-169.
38. Wheeler EF, Bothwell M. 1992. Spatiotemporal patterns of expression of NGF and the low-affinity NGF receptor in rat embryos suggest functional roles in tissue morphogenesis and myogenesis. J Neurosci 12:930-944.
39. Yamamoto M, Sobue G, Yamamoto K, Terao S, Mitsumi T. 1996. Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, TrkA, TrkB, and TrkC) in the adult human peripheral nervous system and nonneuronal tissues. Neurochem Res 21:929-938.
40. Yunis EJ, Samaha FJ. 1971. Inclusion body myositis. Lab Invest 25:240-248.